Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Repligen (RGEN)

Repligen Q4 revenue rises to $168 million; GAAP loss widens on restructuring charges

Mixed Impact 3 of 5 earnings Written later

Repligen reported fourth-quarter 2024 revenue of $168 million, up from $167 million, but swung to a GAAP operating loss of $(37) million from $10 million of operating income a year earlier, largely due to $45 million in restructuring and inventory charges. The company also issued 2025 guidance of $685 million to $710 million in reported revenue and GAAP diluted EPS of $0.90 to $0.99, which shareholders can compare with the weaker 2024 profit.

Key points

  • Q4 2024 revenue was $168 million versus $167 million a year earlier; full-year 2024 revenue was $634 million versus $632 million.
  • Q4 GAAP diluted EPS was $(0.60) versus $(0.29); adjusted EPS was $0.44 versus $0.48.
  • Q4 GAAP operating loss of $(37) million included $45 million in non-recurring restructuring and other inventory charges.
  • 2025 guidance: total reported revenue of $685 million to $710 million and GAAP diluted EPS of $0.90 to $0.99.

The filing

CompanyRepligen (RGEN)
Form8-K, current report
Filed with the SECFeb 20, 2025, 7:45 AM ET
Accession number0000950170-25-023742

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.